Medsix is a healthcare technology startup that operates in the medical device market, specifically focusing on post-surgical care. Its primary product is WHISPER, a real-time monitoring system for anastomotic leaks. Anastomotic leaks are a common postoperative complication where a surgical connection between two parts of the intestines or blood vessels leaks fluids.

The company's innovative technology addresses a significant problem in the healthcare industry. Currently, over 10 million surgeries in the United States require the installation of a drain to collect and dispose of excess fluids as the body heals. The color and volume of this drain output are visually inspected for complications such as leaks, excessive bleeding, blockages, and infections. However, this method is prone to delays in detecting complications, leading to longer hospital stays, increased costs, and higher mortality rates.

Medsix's WHISPER system uses novel sensors for wound drainage monitoring and predictive tools to improve patient outcomes. By providing real-time monitoring, it can detect complications such as anastomotic leaks much faster than traditional methods, reducing the current 2-3 day delay. This early detection can potentially save hospitals $45k per incident and significantly reduce the 12% mortality rate associated with anastomotic leaks.

Medsix's business model is likely based on selling its WHISPER devices to hospitals and surgical centers. The company may also generate revenue from ongoing service or subscription fees for access to its predictive tools and data analytics.

Keywords: Healthcare Technology, Medical Device, Post-Surgical Care, Anastomotic Leaks, Real-Time Monitoring, Wound Drainage, Predictive Tools, Patient Outcomes, Cost Reduction, Mortality Rate Reduction.